top of page
Search

Cell & Gene Therapy Drug Delivery Devices Market: Share, Size, Growth, and Industry Trends – Report for 2023-2028

  • Writer: Amit Kumar
    Amit Kumar
  • Jan 23, 2024
  • 3 min read


MarkNtel Advisors who is leading market research company, has recently published a research report, titled Global “Cell & Gene Therapy Drug Delivery Devices Market”. The report is estimated historical data, base year and forecast period and the projections are made for the next five years, i.e., 2023-28. The data, facts, and figures are sourced from reliable platforms, including government portals, white papers, and others.


Important Notes: In case you missed it, we are currently revising our reports. Click on the "request Sample report" button to get the most latest research data with forecast for years 2024 to 2030, including market size, industry trends, and competitive analysis. It wouldn't take long for the team to deliver the most recent version of the report.


Market Study Period

Historical Data: 2018-21

Base Year: 2022

Forecast Period: 2023-28

CAGR (2023-2028): 14%


Global Cell & Gene Therapy Drug Delivery Devices Market Insights:

The Global Cell & Gene Therapy Drug Delivery Devices Market is anticipated to grow at a CAGR of around 14% during the forecast period, i.e., 2023-28, says MarkNtel Advisors. The report covers each and every aspect of the market in detail, offering actionable insights to the stakeholders. We extensively cover key trends, opportunities, possible challenges, and major growth drivers for the industry. The report also highlights the role and involvement of governments and other relevant factors that promote market growth.


Global Cell & Gene Therapy Drug Delivery Devices Market Drivers:

The factors that are projected to drive the market in the coming years include the following:

  • Substantial investments in R&D, particularly across the US, for the development of new & improved cell & gene therapies

  • Mounting prevalence of genetic disorders & chronic diseases

  • An increasing number of FDA approvals for cell & gene therapies & their clinical trials


Explore the Complete Cell & Gene Therapy Drug Delivery Devices Market Analysis Report - https://www.marknteladvisors.com/research-library/cell-gene-therapy-drug-delivery-devices-market.html


Which segments are covered in the Cell & Gene Therapy Drug Delivery Devices Market Research Report?

  • By Product Type

  • Sub-retinal Injection Cannula

  • Extension Tube

  • Intravenous Catheter

  • Sterile Insulin Syringe

  • Size 1.0 ML, 31-Gauge Needle

  • Size 0.5 ML, 22-Gauge Needle

  • Pre-Filled Syringe

  • Size 1.0 ML, 22-26 Gauge Needle

  • Size 4.0 ML, 22-26 Gauge Needle

  • Infusion Bags

  • Infusion Bags (Size 10 ML to 50 ML)

  • Infusion Bags (Size 68 ML)

  • Infusion Bags (Size 60 ML)

  • Infusion Bags (Size Up to 65 ML)

  • By Technology

  • Microchip Technology

  • Nano-Technology

  • Lipid Nanoparticles

  • By Commercialized Drugs

  • Luxturna

  • Kymriah

  • Yescarta

  • Zolgensma

  • Provenge

  • Strimvelis

  • By End-User

  • Pharmaceuticals & Biotechnology Company

  • Academic & Research Institute

  • Hospitals & Clinics

  • By Region

  • North America

  • South America

  • Europe

  • Middle East & Africa

  • Asia-Pacific


Top 10 Key Brands/Players in the Cell & Gene Therapy Drug Delivery Devices Market

Our analysts have closely analyzed leading players within the industry, providing stakeholders with valuable insights into the competitive landscape. This enables them to formulate strategic tactics based on the comprehensive data compiled in the report. The information encompasses recent developments, mergers and acquisitions, product/service launches, expansion plans, and revenue-generating opportunities. Notable entities featured in the report include:

  • Amgen Inc.

  • Bausch & Lomb Incorporated

  • Becton, Dickinson and Company

  • Bluebird bio Inc.

  • Castle Creek Biosciences, Inc. (Fibrocell Science, Inc.)

  • Dendreon Pharmaceuticals LLC

  • Helixmith Co. Ltd (ViroMed Co., Ltd)

  • Human Stem Cells Institute

  • Kite Pharma Inc.

  • Kolon TissueGene, Inc.

  • Novartis AG

  • Orchard Therapeutics plc.

  • Pfizer Inc.

  • Renova Therapeutics

  • Spark Therapeutics Inc.

  • uniQure N.V.

  • Vericel Corporation



Frequently Asked Questions

  1. Which companies dominate the Cell & Gene Therapy Drug Delivery Devices Market in terms of market share?

  2. What is the projected market size of Cell & Gene Therapy Drug Delivery Devices Market in 2028?

  3. What key factor is anticipated to propel the Cell & Gene Therapy Drug Delivery Devices Market by 2028?

  4. How big is the Cell & Gene Therapy Drug Delivery Devices Market?


Other Reports –


About us:

Confronting a market challenge? MarkNtel is here to support you. We specialize in in-depth analysis across 15 dynamic industries, providing customized research, consulting, and data solutions to meet your specific requirements. Whether it's launching a product or gaining a competitive edge, we facilitate well-informed decisions that pave the way for enduring success.

 

Empowering your financial future is our commitment at MarkNtel. Serving as your trusted research partner, we navigate intricate markets, pinpoint high-potential opportunities, and formulate early-stage strategies for superior returns. Allow us to illuminate your path to financial prosperity.


Contact us:

Should you have any inquiries, our team of seasoned experts is available to help. You can contact us via phone, email, or by filling out our online contact form. Be assured that we will exert every effort to promptly attend to your query and furnish the necessary information.


Media Representative

Phone: +1 628 895 8081

 
 
 

Comments

bottom of page